Asklepios BioPharmaceutical Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Asklepios BioPharmaceutical Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011821
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Asklepios Biopharmaceutical Inc (AskBio) is a biotechnology company that develops and markets novel protein and cellular based therapies. The company has developed library of rAAV biological nano particles that provides unsurpassed transduction. Its products include such as biostrophin, AskBio009, BNP-CHF, BNP-TLE, BNP-FVIII, BNP-RP and BNP-OA. AskBio also offers products for the treatment of muscular dystrophy, hemophilia B, congestive heart failure, epilepsy, hemophilia A, retinitis pigmentos a and osteoarthritis. The company collaborates with corporate, foundation, and academic organizations. It caters to pharmaceutical and biotechnology companies throughout the country. AskBio is headquartered in Chapel Hill, North Carolina, the US.

Asklepios BioPharmaceutical Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Asklepios BioPharmaceutical Inc, Medical Devices Deals, 2011 to YTD 2017 9
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Asklepios BioPharma Forms Joint Venture with Columbus Venture 11
Licensing Agreements 12
Calimmune Enters into Licensing Agreement with Asklepios BioPharma 12
Asklepios BioPharma Enters into Licensing Agreement with AveXis 13
Benitec Biopharma Enters into Licensing Agreement with Asklepios BioPharma 14
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Duplex Gene Therapy Vector Technology 15
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Intra-Strand Base-Pairing Technology 16
Asklepios BioPharma Enters Into Licensing Agreement With REGENX Biosciences For Hemophilia A 17
Acquisition 18
Baxter International Acquires Chatham Therapeutics from Asklepios BioPharma 18
Asklepios BioPharmaceutical Inc – Key Competitors 19
Asklepios BioPharmaceutical Inc – Key Employees 20
Asklepios BioPharmaceutical Inc – Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Key Facts 2
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Asklepios BioPharmaceutical Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Asklepios BioPharmaceutical Inc, Medical Devices Deals, 2011 to YTD 2017 9
Asklepios BioPharmaceutical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Asklepios BioPharma Forms Joint Venture with Columbus Venture 11
Calimmune Enters into Licensing Agreement with Asklepios BioPharma 12
Asklepios BioPharma Enters into Licensing Agreement with AveXis 13
Benitec Biopharma Enters into Licensing Agreement with Asklepios BioPharma 14
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Duplex Gene Therapy Vector Technology 15
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Intra-Strand Base-Pairing Technology 16
Asklepios BioPharma Enters Into Licensing Agreement With REGENX Biosciences For Hemophilia A 17
Baxter International Acquires Chatham Therapeutics from Asklepios BioPharma 18
Asklepios BioPharmaceutical Inc, Key Competitors 19
Asklepios BioPharmaceutical Inc, Key Employees 20

★海外企業調査レポート[Asklepios BioPharmaceutical Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Adhezion Biomedical, LLC:企業のM&A・提携動向(医療機器分野)
    Summary Adhezion Biomedical, LLC (Adhezion) is a medical device company that develops and commercializes cyanoacrylate based surgical, wound management and infection prevention technologies. The company offers professional products such as surgical splution, wound management, and infection preventio …
  • Hiab Oy:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Hiab Oy Mergers and Acquisition …
  • Chien Shing Stainless Steel Co., Ltd:企業の戦略・SWOT・財務分析
    SummaryChien Shing Stainless Steel Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the …
  • SOCO International plc (SIA):企業のM&A・提携動向(石油・ガス分野)
    Summary SOCO International plc (SOCO) is an oil and gas company that offers explores, produces, discovers and produces oil and gas reserves. The company provides appraisal and field development and production. It offers training and skills and support local communities. SOCO produces and supplies na …
  • Heart Test Laboratories Inc:企業のM&A・提携動向(医療機器分野)
    Summary Heart Test Laboratories Inc (HTL) is a medical device company that offers cardiac care products. The company develops life saving devices for the coronary arterial disease market. Its product MyoVista is a screening tool used to determine the presence and level of myocardial abnormalities an …
  • Reliance Steel & Aluminum Co:戦略・SWOT・企業財務分析
    Reliance Steel & Aluminum Co - Strategy, SWOT and Corporate Finance Report Summary Reliance Steel & Aluminum Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • BASF SEの企業概要及び財務/SWOT分析
    BASF SE Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, BASF SE annual and quarterly forecasts made by stock market experts. The report also enables direct comparison to be m …
  • Indorama Ventures PCL (IVL):企業財務及び戦略的SWOT分析
    Summary Indorama Ventures PCL (Indorama), a subsidiary of The Indorama Group is a chemical company that manufactures and distributes petrochemicals and wool yarns. The company’s products include PET polymers, EO/EG, polyester fibers, yarns, chips and wool. It also provides purified terphthalic acid …
  • Eesti Energia AS:企業の戦略的SWOT分析
    Eesti Energia AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Saipem SpA (SPM)-石油・ガス分野:企業M&A・提携分析
    Summary Saipem SpA (Saipem) is an engineering, procurement, construction (EPC) contractor. It provides integrated basic design, Pre-front end engineering design (FEED), FEED and detailed EPC and project management services for complex offshore and onshore projects in the oil and gas industry. The co …
  • Clemex Technologies Inc. (CXG.A):企業概要、財務及び戦略的SWOT分析
    Summary Clemex Technologies Inc. (Clemex) is an image analysis system manufacturer. The company designs, develops and supplies image analysis systems and software for research and quality control laboratories. Its specific image analysis products include clemex CMT.HD, clemex PSFilter, clemex PSA, c …
  • XenoPort Inc-製薬・医療分野:企業M&A・提携分析
    Summary XenoPort Inc (XenoPort) is a bio-pharmaceutical company which develops and commercializes internally discovered product candidates for the treatment of neurological disorders. It develops Transported Prodrugs through the modification of chemical structure of existing drugs in the market. The …
  • The Zubair Corporation LLC:企業のM&A・提携動向(発電分野)
    Summary The Zubair Corporation LLC (Zubair) is a business consulting and services company that offers support and investment services. The company operates through business areas such as energy and logistics, engineering, construction and contracting, information and communication technology, real e …
  • Bronfman Fisher Investments Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Bronfman Fisher Investments Ltd …
  • GenMark Diagnostics Inc (GNMK):企業のM&A・提携動向(医療機器分野)
    Summary GenMark Diagnostics Inc (GenMark) is a medical device company that offers clinical testing solutions. The company’s products include XT-8 systems and assays. It offers pipeline products such as eSensor 2C 19 genotyping test, eSensor 3A4/3A5 genotyping test, eSensor HCV genotyping test and eS …
  • Church and Dwight Co., Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Church and Dwight Co., Inc. Mer …
  • Nisshinbo Holdings Inc. (3105):企業の財務・戦略的SWOT分析
    Nisshinbo Holdings Inc. (3105) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Nordic Semiconductor ASAの企業概要及び財務/SWOT分析
    Nordic Semiconductor ASA Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Nordic Semiconductor ASA annual and quarterly forecasts made by stock market experts. The report also …
  • Avago Technologies Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Avago Technologies Limited Merg …
  • Costar Midstream, L.L.C.(石油・ガス分野):企業M&A動向
    Summary Costar Midstream, L.L.C.,(Costar) is a midstream oil and gas company. It focuses on acquisition, development, and operation of midstream infrastructure assets. The company specializes in offering engineering, operating and marketing solutions for producer needs for midstream infrastructure. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆